Halozyme Therapeutics, Inc.

CANADA PENSION PLAN INVESTMENT BOARD HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

363,100

Value ($000)

24,437

Weight

0.0%

2014 Q1 - 2025 Q4 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	24,437	0.0%	363,100	12/31/2025
2025 Q3	11/13/2025	17,103	0.0%	233,200	9/30/2025
2025 Q2	8/14/2025	7,907	0.0%	152,000	6/30/2025
2025 Q1	5/15/2025	6,962	0.0%	109,100	3/31/2025
2024 Q4	2/13/2025	8,520	0.0%	178,200	12/31/2024
2024 Q3	11/14/2024	5,735	0.0%	100,200	9/30/2024
2024 Q2	8/12/2024	9,016	0.0%	172,200	6/30/2024
2024 Q1	5/14/2024	7,005	0.0%	172,200	3/31/2024
2023 Q4	2/14/2024	6,365	0.0%	172,200	12/31/2023
2023 Q3	11/9/2023	1,879	0.0%	49,200	9/30/2023
2023 Q2	8/9/2023	2,384	0.0%	66,100	6/30/2023
2023 Q1	5/15/2023	1,638	0.0%	42,900	3/31/2023
2022 Q1	5/13/2022	10	0.0%	257	3/31/2022
2021 Q4	2/14/2022	564	0.0%	14,030	12/31/2021
2021 Q3	11/15/2021	191	0.0%	4,695	9/30/2021
2021 Q2	11/16/2021	52	0.0%	1,141	6/30/2021
2020 Q4	2/17/2021	286	0.0%	6,700	12/31/2020
2020 Q2	8/14/2020	3,113	0.0%	116,100	6/30/2020
2019 Q4	2/14/2020	2,963	0.0%	167,100	12/31/2019
2014 Q1	5/9/2014	44	0.0%	3,500	3/31/2014